Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janet E Pope

Showing results (141-150 of 299) with videos related to

Pageof 30
Sort By:
Seminars in Arthritis and Rheumatism|March 16, 2007
Campylobacter reactive arthritis: a systematic reviewJanet E Pope, Adriana Krizova, Amit X Garg, et al.
Rheumatology (Oxford, England)|July 31, 2019
Changes in skin score in early diffuse cutaneous systemic sclerosis are associated with changes in global disease severityBoyang Zheng, Tatiana Nevskaya, Carl A Baxter, et al.
Rheumatology (Oxford, England)|November 28, 2019
Skin improvement is a surrogate for favourable changes in other organ systems in early diffuse cutaneous systemic sclerosisTatiana Nevskaya, Boyang Zheng, Carl A Baxter, et al.
Advances in Therapy|August 22, 2018
Efficacy of Monotherapy with Biologics and JAK Inhibitors for the Treatment of Rheumatoid Arthritis: A Systematic ReviewPaul Emery, Janet E Pope, Klaus Kruger, et al.
European Journal of Rheumatology|November 9, 2020
Systemic sclerosis: To subset or not to subset, that is the questionSindhu R Johnson, Frank van den Hoogen, Keshini Devakandan, et al.
Pain Research & Management|July 23, 2016
Dispositional Affect in Unique Subgroups of Patients with Rheumatoid ArthritisDanielle B Rice, Swati Mehta, Janet E Pope, et al.
Therapeutic Advances in Musculoskeletal Disease|October 24, 2024
What have we learnt from the inhibition of IL-6 in RA and what are the clinical opportunities for patient outcomes?Peter C Taylor, Eugen Feist, Janet E Pope, et al.
Journal of the Canadian Association of Gastroenterology|August 14, 2024
Practical guidance for managing patients with moderate-to-severe ulcerative colitis using small molecule therapiesVipul Jairath, Waqqas Afif, Brian Bressler, et al.
Rheumatology and Therapy|May 23, 2026
Real-World Upadacitinib Persistence and Clinical Outcomes Among Canadian Patients with Inflammatory Arthritis from a Patient Support Program: The UPRAISE StudyJanet E Pope, Jayeshkumar Patel, Christopher D Saffore, et al.
Arthritis Care & Research|June 17, 2018
Pragmaticism of Randomized Controlled Trials of Biologic Treatment With Methotrexate in Rheumatoid Arthritis: A Systematic ReviewMay Y Choi, Cheryl Barnabe, Claire E Barber, et al.
Pageof 30

Showing results (141-150 of 299) with videos related to

Sort By:
Pageof 30
Seminars in Arthritis and Rheumatism|March 16, 2007
Campylobacter reactive arthritis: a systematic reviewJanet E Pope, Adriana Krizova, Amit X Garg, et al.
Rheumatology (Oxford, England)|July 31, 2019
Changes in skin score in early diffuse cutaneous systemic sclerosis are associated with changes in global disease severityBoyang Zheng, Tatiana Nevskaya, Carl A Baxter, et al.
Rheumatology (Oxford, England)|November 28, 2019
Skin improvement is a surrogate for favourable changes in other organ systems in early diffuse cutaneous systemic sclerosisTatiana Nevskaya, Boyang Zheng, Carl A Baxter, et al.
Advances in Therapy|August 22, 2018
Efficacy of Monotherapy with Biologics and JAK Inhibitors for the Treatment of Rheumatoid Arthritis: A Systematic ReviewPaul Emery, Janet E Pope, Klaus Kruger, et al.
European Journal of Rheumatology|November 9, 2020
Systemic sclerosis: To subset or not to subset, that is the questionSindhu R Johnson, Frank van den Hoogen, Keshini Devakandan, et al.
Pain Research & Management|July 23, 2016
Dispositional Affect in Unique Subgroups of Patients with Rheumatoid ArthritisDanielle B Rice, Swati Mehta, Janet E Pope, et al.
Therapeutic Advances in Musculoskeletal Disease|October 24, 2024
What have we learnt from the inhibition of IL-6 in RA and what are the clinical opportunities for patient outcomes?Peter C Taylor, Eugen Feist, Janet E Pope, et al.
Journal of the Canadian Association of Gastroenterology|August 14, 2024
Practical guidance for managing patients with moderate-to-severe ulcerative colitis using small molecule therapiesVipul Jairath, Waqqas Afif, Brian Bressler, et al.
Rheumatology and Therapy|May 23, 2026
Real-World Upadacitinib Persistence and Clinical Outcomes Among Canadian Patients with Inflammatory Arthritis from a Patient Support Program: The UPRAISE StudyJanet E Pope, Jayeshkumar Patel, Christopher D Saffore, et al.
Arthritis Care & Research|June 17, 2018
Pragmaticism of Randomized Controlled Trials of Biologic Treatment With Methotrexate in Rheumatoid Arthritis: A Systematic ReviewMay Y Choi, Cheryl Barnabe, Claire E Barber, et al.
Pageof 30